期刊文献+

应用血清降钙素原浓度指导抗生素治疗急性脑梗死发热的效果分析 被引量:3

The value of serum procalcitonin in treatment of pyrexia after acute cerebral infarction
原文传递
导出
摘要 目的研究血清降钙素原(PCT)测定在急性脑梗死后发热治疗中的作用。方法选取2005年9月至2007年11月年复旦大学附属上海市第五人民医院住院的急性脑梗死伴发热患者133例,分为常规治疗组66例(常规组)和PCT指导治疗组67例(PCT组)。常规组由经治医生按照抗生素使用指南决定抗生素治疗方案,PCT组按照血清PCT质量浓度决定是否使用抗生素。观察两组患者的住院时间、临床有效率、住院费用、抗生素费用、抗生素使用率以及治疗后28d病死率、美国国立卫生院卒中量表(NIHSS)评分和Barthel指数评分(BI)。结果两组患者在住院时间、临床有效率、治疗后28d病死率、NIHSS评分和BI指数方面比较,差异无统计学意义,PCT组的平均住院费用、抗生素费用及抗生素使用率[分别为6558(3774,9647)元、2673(1352,5287)元、70.1%]均低于常规组[分别为8373(4852,12533)元、4194(2869,7055)元、85.7%](均P<0.05)。结论急性脑梗死伴发热患者在PCT指导下使用抗生素,能够减少抗生素使用量,降低平均住院费用。 Objective To evaluate the value of serum procalcitonin(PCT) in treatment of pyrexia after acute cerebral infarction. Methods A total of 133 patients requiring hospitalization for acute cerebral infarction were randomly assigned into two groups : standard therapy group ( standard group, n = 66 ) and PCT-gnided group ( PCT group, n = 67 ). Standard group received antibiotics according to the attending physicians and PCT group were treated with antibiotics according to serum PCT levels. Length of hospitalization, clinical efficacy, costs of hospitalization and antibiotics, rate of antibiotics use, mortality, NIHSS and BI on the 28th day were observed. Results Length of hospitalization, clinical efficacy, mortality, NIHSS and BI on the 28th day were similar in two groups. Costs of hospitalization and antibiotics and rate of antibiotics use in PCT group[ 6558 ( 3774,9647 ) yuan, 2673 ( 1352,5287 ) yuan, 70. 1% ] were lower than those in standard group [8373(4852,12533)ynan,4194(2869,7055)yuan,85. 7% ] (P 〈0. 05). Conclusion PCT guidance reduced antibiotics use and lowered costs of hospitalization in treatment of pyrexia after acute cerebral infarction.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第2期150-152,共3页 Chinese Journal of Practical Internal Medicine
关键词 降钙素原 脑梗死 发热 procalcitonin cerebral infarction pyrexia
  • 相关文献

参考文献10

  • 1Hajat C, Hajat S, Sharma P, et al. Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients [ J ]. stroke, 2000,31 (2) :410 -414.
  • 2龙威,邓星奇.降钙素原及其临床应用[J].国外医学(老年医学分册),2004,25(5):216-219. 被引量:19
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 4Kammersgaard LP, Jorgensen HS, Rungby JA, et al. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen stroke study [ J ]. Stroke, 2002,33 ( 7 ) : 1759 - 1762.
  • 5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis : Clinical utility and limitations [J]. Crit Care Med,2008,36(3) :941 -952.
  • 6Pecile P, Miorin E, Romanello C, et al. Procalcitonin : a marker of severity of acute pyelonephritis among children [ J]. 'Pediatrics, 2004,114(2) :e249 - e254.
  • 7屈文烈,王镇山,顾俊明.血清降钙素原 C反应蛋白 内毒素的测定对社区获得性肺炎的诊断价值[J].中国实用内科杂志,2006,26(6):832-833. 被引量:30
  • 8龙威,邓星奇,谢娟,唐建国,高育瑶,陆刚,张奕翠,陆伟,张羽,施劲东,何伟,黄建芳.血清降钙素原测定在慢性阻塞性肺疾病急性加重期治疗中的意义[J].中华急诊医学杂志,2008,17(9):974-977. 被引量:38
  • 9Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients:a randomized trial [ J ]. Am J Respir Cfit Care Med,2008,177 (5) :498 - 505.
  • 10Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized triM[J]. Am J Respir Crit Care Med,2006,174( 1 ) : 84 - 93.

二级参考文献40

  • 1龙威,邓星奇.降钙素原及其临床应用[J].国外医学(老年医学分册),2004,25(5):216-219. 被引量:19
  • 2常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 3Zielinski J, Bednarek M, Gorecka D, et al. Increasing COPD awareness [J]. Eur Respir J,2006,27(4) :833-852.
  • 4Nanshan Z, Chen W, Wanzhen Y, et al. Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey[J]. Am J Respir Crit Care Med,2007,176(8) :753-760.
  • 5Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial[J]. Lancet, 2004( 9409 ),363 : 600-607.
  • 6Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? [ J ]. Ettr Respir J, 2002,20 (Suppl) : 9S- 19S.
  • 7Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rbinoviral infection in exacerbations of COPD [ J]. Chest, 2006,129(2) :317-324.
  • 8Lindenauer PK,Pekow P, Gao S, et al. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease [J]. Ann Intern Med,2006,144(12) :894-903.
  • 9Tugrul S, Esen F, Celebi S, et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response [ J ]. Anaesth Intensive Care, 2002,30 ( 6 ) : 747-754.
  • 10Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial [J].Am J Respir Crit Care Med,2006,174(1):84-93.

共引文献33101

同被引文献20

  • 1屈文烈,王镇山,顾俊明.血清降钙素原 C反应蛋白 内毒素的测定对社区获得性肺炎的诊断价值[J].中国实用内科杂志,2006,26(6):832-833. 被引量:30
  • 2Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients[J]. Stroke, 2000,31 ( 2 ) : 410-414.
  • 3Florence C, Rich e MD, Bernard P, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis[J]. Surgery,2003,133 ( 3 ) : 257-262.
  • 4Vandack N, Stephao H, Jean DG, et al. Use of procaleitonin to shorten antibiotic treatment duration in septic patients[J]. Am J Respir Cfit Care Med, 2008,177,498-505.
  • 5Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia : a randomized trial[J]. Am J Respir Crit Care Med, 2006,174 ( 1 ) : 84-93.
  • 6Ramirez P,Garcia MA,Ferrer M,et al.Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia[J].Eur Respir J,2008,31(2):356-362.
  • 7van Rossum AM,Wulkan RW,Qudesluys-Murphy AM,et al.Procalcitonin as an early marker of infection in neonates and children[J].Lancet Infect Dis,2004,(10):620-630.
  • 8Uzzan B,Cohen R,Nicolas P,et al.Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma:a systematic review and meta-analysis[J].Crit Care Med,2006,34:1 996-2 003.
  • 9Penel N,Fournier C,Degardin M,et al.Fever and solid tumor:diagnostic value of procalcitonin and C-reactive protein[J].Rev Med Interne,2001,22(8):706-714.
  • 10Giamarellos EJ,Grecka P,Poulakou G,et al.Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutrogena[J].Clin Infect Dis,2001,32(12):1 718-1 725.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部